Heart Health, Inflammation, and Metabolic Benefits
Clinical evidence for macadamia nuts reducing LDL cholesterol, lowering oxidative stress and inflammation markers, and supporting heart health through a uniquely high monounsaturated fat profile including the rare omega-7 fatty acid palmitoleic acid.
Macadamia nuts stand out from other tree nuts by having the highest monounsaturated fat content of any nut — over 75% of their calories come from oleic acid and palmitoleic acid, the same heart-healthy fats found in olive oil and cold-water fish. Clinical trials have shown that eating a small daily handful can meaningfully reduce LDL cholesterol, lower markers of oxidative stress and inflammation, and improve the cholesterol ratios most predictive of cardiovascular disease risk — all without causing weight gain. [1][2][4]
What Macadamia Nuts Contain
A 30g serving (roughly 10–12 nuts) provides approximately 200 calories, 21g fat, 2g protein, 2.5g carbohydrate, and 2.5g fibre. The fat profile is what makes macadamia nuts nutritionally distinctive:
- Oleic acid (C18:1, omega-9) — the predominant fat, comprising about 55–60% of total fatty acids. The same monounsaturated fat found in extra-virgin olive oil, oleic acid consistently lowers LDL cholesterol when it replaces saturated fat in the diet.
- Palmitoleic acid (C16:1, omega-7) — macadamia nuts are the richest known whole-food source of this unusual fatty acid, comprising roughly 16–22% of their fat. Palmitoleic acid has attracted research interest for anti-inflammatory effects, metabolic signalling properties, and possible roles in insulin sensitivity. [5]
- Phytosterols — beta-sitosterol and related plant sterols partially block dietary cholesterol absorption in the intestine, contributing to LDL-lowering effects independent of the fatty acid profile.
- Tocopherols (vitamin E) — alpha-tocopherol is the primary form, acting as a fat-soluble antioxidant that protects cell membranes and LDL particles from oxidative damage.
- Squalene — a precursor to steroid hormones and cholesterol that also functions as a skin-protective antioxidant; macadamia nuts contain meaningful concentrations compared to other tree nuts. [5]
- Polyphenols and flavonoids — concentrated in the outer layers of the kernel, where they contribute antioxidant capacity. Roasting tends to increase total polyphenol availability by breaking down cell wall structures that otherwise limit extraction. [6]
Macadamia nuts are low in omega-6 polyunsaturated fat relative to most other nuts — walnuts, almonds, and sunflower seeds are all substantially higher in linoleic acid. For people consuming a diet already high in omega-6, macadamia nuts represent a nut option that adds monounsaturated fat without further widening the omega-6:omega-3 ratio.
Cardiovascular Health
Multiple controlled trials confirm that macadamia nut consumption, when substituted for less heart-healthy foods, reduces LDL cholesterol and improves lipid ratios associated with cardiovascular risk.
Garg et al. (2003) gave 17 hypercholesterolaemic men 40–90g of macadamia nuts per day (representing 15% of total energy intake) for four weeks. Total cholesterol dropped by 3.0%, LDL fell by 5.3%, and HDL — the protective lipoprotein — rose by 7.9%. [1] Plasma monounsaturated fatty acids increased while saturated fatty acids decreased, confirming that the nuts were successfully displacing saturated fat sources in participants' diets. Triglycerides and homocysteine were unchanged, which is consistent with the specific mechanism: macadamia nuts appear to work primarily through the LDL pathway rather than affecting triglyceride metabolism.
Griel et al. (2008) conducted a more rigorous 5-week randomised crossover feeding study comparing a macadamia nut-rich diet (42.5g/day) against a typical American diet in 25 mildly hypercholesterolaemic men and women. [2] Total cholesterol dropped to 4.94 mmol/L versus 5.45 mmol/L on the standard diet; LDL fell to 3.14 mmol/L versus 3.44 mmol/L. Non-HDL cholesterol — a measure that includes all atherogenic lipoproteins — also fell significantly, as did the total cholesterol-to-HDL and LDL-to-HDL ratios. These ratios are among the most clinically useful predictors of cardiovascular event risk.
Jones et al. (2023) examined a population with greater metabolic risk — adults with abdominal obesity — over an 8-week crossover trial. LDL fell by a non-statistically significant 4% (−4.7 mg/dL), with greater effects in participants classified as overweight compared to obese. [3] The lack of significance in this population may reflect that adiposity modifies lipid metabolism, or simply that the study was underpowered for the effect size observed. The direction of effect remained consistent with earlier trials.
Practical dose: Most trials delivering measurable cardiovascular benefit used 30–45g per day (roughly 10–15 nuts). At this serving size the caloric contribution is approximately 200 calories — easily accommodated by replacing refined carbohydrate snacks or less healthy fat sources.
Anti-Inflammatory and Antioxidant Effects
Beyond lipid profiles, macadamia nuts appear to reduce markers of both oxidative stress and inflammation — two processes that underlie atherosclerosis, metabolic disease, and ageing more broadly.
Garg et al. (2007) used the same cohort of hypercholesterolaemic men and extended the analysis to inflammation and oxidative stress markers. [4] After four weeks of daily macadamia nut consumption, plasma leukotriene B4 (LTB4, a pro-inflammatory eicosanoid produced by white blood cells) dropped from 1,353 to 1,030 pg/mL — a 24% reduction. The oxidative stress marker 8-isoprostane (formed when free radicals attack cell membrane fats) fell from 876 to 679 pg/mL — a 22% reduction. The thromboxane-to-prostacyclin ratio (TXB2/PGI2) — reflecting a balance between pro-clotting and anti-clotting signals in the blood — fell by 23.6%, though this did not reach statistical significance. These findings suggest that macadamia nut consumption actively counters the inflammatory and oxidative processes driving atherosclerosis, not merely adjusting cholesterol levels as a downstream marker.
The likely mechanisms involve the antioxidant vitamin E protecting against lipid peroxidation, the anti-inflammatory properties of oleic and palmitoleic acid modulating eicosanoid production, and polyphenols inhibiting inflammatory transcription factors including NF-kB. [6]
Palmitoleic Acid: A Distinctive Fatty Acid
Palmitoleic acid (C16:1n-7, omega-7) is a monounsaturated fat produced in small amounts by the liver and found in notably high concentrations in macadamia nuts and sea buckthorn. It has attracted research interest beyond its role in lipid profiles.
As a lipokine — a fatty acid that acts as a hormone-like signal — palmitoleic acid regulates communication between the liver and muscles regarding glucose and lipid metabolism. Animal studies have demonstrated that palmitoleic acid supplementation attenuates atherosclerosis progression and reduces LDL. [5] Emerging evidence also suggests anti-inflammatory effects: palmitoleic acid inhibits LPS-induced inflammation in immune cells and has been shown to protect neurons from saturated fat-induced damage.
In whole-food form from macadamia nuts, the concentrations of palmitoleic acid delivered per serving are meaningful — roughly 3–4g per 30g serving — but lower than the pharmacological doses used in mechanistic research. The clinical significance of this palmitoleic acid content in humans eating macadamia nuts as a whole food remains an active area of investigation. See our sea buckthorn page for more on palmitoleic acid research.
Weight and Body Composition
Despite being calorie-dense, macadamia nuts — like other tree nuts — do not appear to cause weight gain in controlled trials. Jones et al. (2023) found no significant change in weight, BMI, waist circumference, or body fat percentage after 8 weeks of daily macadamia nut consumption despite participants adding approximately 15% of their daily calories from the nuts. [3]
Several mechanisms explain this: high fat content produces strong satiety signals via cholecystokinin and other gut hormones, slowing gastric emptying and reducing appetite at subsequent meals; the intact cellular structure of the nuts means some of the fat is encased in plant cells that resist digestion and is excreted rather than absorbed; and the protein and fibre content contributes to satiety.
For weight management, macadamia nuts are most effectively used as a replacement for less satiating foods rather than as an addition to an unchanged diet. See our nuts and seeds page for a broader comparison of tree nuts and their satiety research.
How to Buy and Eat Them
Macadamia nuts are sold raw, dry-roasted, and oil-roasted. For health purposes:
- Raw or dry-roasted are preferable — oil-roasting adds extra fat and sometimes uses lower-quality seed oils.
- Unsalted varieties allow better control of sodium intake, though lightly salted options are unlikely to be problematic for most people.
- Storage: Macadamia nuts have a higher fat content than most nuts, making them more susceptible to rancidity. Store in an airtight container in the refrigerator or freezer for maximum shelf life; at room temperature in a cool, dark pantry they stay fresh for 2–4 weeks after opening.
- Whole form: As with almonds and walnuts, consuming whole nuts rather than nut butter or flour preserves the cellular structure and maximises both satiety and the fraction of fat that remains unabsorbed.
A practical serving is 10–15 nuts (28–42g), eaten as a snack or added to salads, grain bowls, or yoghurt.
Evidence Review
LDL Cholesterol Reduction in Hypercholesterolaemic Men
Garg, Blake, and Wills (2003) enrolled 17 hypercholesterolaemic men (mean age 54 years, mean total cholesterol in the elevated range) in an uncontrolled intervention in which macadamia nuts replaced a portion of habitual dietary fat for four weeks. [1] The nuts provided 40–90g per day, calibrated to represent approximately 15% of each participant's total energy intake. At the end of the intervention:
- Total cholesterol fell by 3.0%
- LDL cholesterol fell by 5.3%
- HDL cholesterol rose by 7.9%
- Triglycerides and plasma homocysteine remained unchanged
Plasma fatty acid analysis confirmed compliance: monounsaturated fatty acid levels in plasma increased while saturated fatty acid levels decreased, consistent with macadamia nuts displacing saturated fat sources in the diet. The uncontrolled design (no comparator arm) is a limitation, but the directional effects are mechanistically plausible and consistent with the controlled trial evidence that followed. The HDL rise is particularly noteworthy — most dietary interventions that lower LDL do not simultaneously raise HDL.
Controlled Feeding Study: Lipid Profiles and Ratios
Griel et al. (2008) conducted a more rigorous randomised crossover controlled feeding study that remains the most methodologically robust human trial on macadamia nuts and lipid profiles. [2] Twenty-five mildly hypercholesterolaemic adults (15 female, 10 male) consumed two 5-week dietary phases in random order, with dietary counselling and food provision to ensure compliance. The macadamia nut diet provided 42.5g/day (approximately 18% of calories from monounsaturated fat) versus a typical American diet (approximately 11% of calories from monounsaturated fat, with the remaining fat primarily saturated).
Results at the end of the macadamia nut phase compared to the standard diet phase:
- Total cholesterol: 4.94 vs. 5.45 mmol/L (p < 0.05)
- LDL cholesterol: 3.14 vs. 3.44 mmol/L (p < 0.05)
- Total cholesterol:HDL ratio: reduced significantly
- LDL:HDL ratio: reduced significantly
- Non-HDL cholesterol: reduced significantly
- Triglycerides: no significant change
The study design (controlled feeding eliminates the confounders typical of free-living dietary trials) and the statistical significance across multiple lipid endpoints make these findings among the strongest in the macadamia literature. The lipid ratio improvements are clinically meaningful — the LDL-to-HDL ratio and total cholesterol-to-HDL ratio are stronger predictors of cardiovascular risk than LDL alone.
Cardiometabolic Risk in Adults with Abdominal Obesity
Jones et al. (2023) recruited 35 adults with abdominal obesity in an 8-week randomised crossover trial, representing the most recent and highest-risk population studied. [3] Participants consumed their usual diet supplemented with macadamia nuts (~15% of daily calories) or their usual diet without nuts, separated by a 2-week washout. Primary outcomes included total cholesterol, LDL, HDL, triglycerides, glucose, insulin, blood pressure, weight, and body composition.
Key results:
- LDL: −4.7 mg/dL (−4.0%) in the nut phase vs. control, not statistically significant (p = 0.11)
- Total cholesterol: −4.3 mg/dL (−2.1%), not statistically significant
- Body weight, BMI, waist circumference, body fat: no significant change in either direction
- Subgroup analysis: lipid-lowering effects were significantly greater in participants with overweight (BMI 25–29.9) than in those with obesity (BMI ≥30), suggesting adiposity modifies the metabolic response to macadamia nut consumption
The absence of statistical significance for the primary lipid outcomes may reflect the modest sample size (35 participants), the short duration, individual variability in lipid response to dietary fat, or a genuine attenuation of the cholesterol-lowering effect in more obese individuals. The directional consistency with earlier trials, and the adiposity-modifying subgroup finding, remain informative for clinical application.
Oxidative Stress and Inflammation Markers
Garg, Blake, Wills, and Clayton (2007) extended the analysis from the 2003 cohort to measure inflammation and oxidative stress biomarkers — outcomes not examined in most nut trials. [4] After four weeks of macadamia nut consumption (same protocol as the 2003 study):
- Plasma leukotriene B4 (LTB4): 1,353 ± 225 → 1,030 ± 129 pg/mL (−24%, p < 0.05). LTB4 is a potent pro-inflammatory eicosanoid derived from arachidonic acid, released by neutrophils and macrophages during immune activation and plaque formation.
- 8-Isoprostane: 876 ± 97 → 679 ± 116 pg/mL (−22%, p < 0.05). 8-Isoprostane is formed in vivo when free radicals oxidise arachidonic acid in cell membranes — its plasma level is a validated biomarker of systemic oxidative stress.
- TXB2/PGI2 ratio: fell by 23.6% (not statistically significant). This ratio reflects the balance between thromboxane A2 (pro-aggregatory, pro-constrictive) and prostacyclin (anti-aggregatory, vasodilatory) — a higher ratio is associated with greater thrombotic risk.
These findings extend the cardiovascular benefit of macadamia nuts beyond lipid modification. Chronic low-grade oxidative stress and inflammation are mechanistically upstream of atherosclerotic plaque development, endothelial dysfunction, and plaque rupture. A dietary intervention that reduces both lipid levels and these inflammatory/oxidative processes addresses atherosclerosis through complementary mechanisms.
Phytochemical and Fatty Acid Composition
Maguire et al. (2004) performed a comparative analysis of the fatty acid profile, tocopherol content, squalene, and phytosterol content of five common tree nuts including macadamia. [5] Key findings for macadamia nuts:
- Palmitoleic acid (C16:1): present at substantial levels, higher than the other four nuts studied (walnuts, almonds, peanuts, hazelnuts)
- Phytosterols: beta-sitosterol dominated, contributing to the cholesterol-absorption-blocking capacity of the nuts
- Tocopherols: alpha-tocopherol was the primary form, providing antioxidant protection for the highly unsaturated nut lipids
- Squalene: present at levels comparable to other nuts, contributing to the fat-soluble antioxidant activity
The high palmitoleic acid content is macadamia nuts' most compositionally distinctive feature relative to other common tree nuts. It explains some of the differential anti-inflammatory effects observed in trials, though isolating the palmitoleic acid contribution from the overall fatty acid effect in whole-food studies is not possible without supplementation trials.
Phytochemical Bioactivity Across the Tree Nut Family
Bolling et al. (2011) conducted a comprehensive systematic review of phytochemical composition and antioxidant capacity across nine tree nut species including macadamia. [6] The review found that all tree nuts contain meaningful concentrations of carotenoids, phenolic acids, phytosterols, flavonoids, proanthocyanidins, and stilbenes, with the specific profile varying by species. For macadamia nuts, the phenolic acid and phytosterol content contributes to antioxidant capacity that complements the tocopherol-based antioxidant action. The review also examined how factors including genotype, growing conditions, harvest timing, storage, and processing affect phytochemical content — important context for interpreting any given study using commercially sourced nuts.
Strength of Evidence
The cholesterol-lowering evidence for macadamia nuts is moderate-to-strong: two controlled trials (including one rigorous crossover feeding study) and one additional uncontrolled intervention all show consistent LDL reduction in the 3–8% range, with improvements in clinically relevant lipid ratios. The 2023 RCT in an obese population showed attenuated effects, suggesting the cholesterol-lowering response may be greater in those with lower adiposity — an important nuance for clinical application.
The inflammation and oxidative stress evidence from Garg et al. (2007) is mechanistically compelling but comes from a single uncontrolled study in a small cohort. Replication in a controlled design is needed to firmly establish these effects.
The evidence base for macadamia nuts is smaller than for almonds or walnuts, which have been more extensively studied. However, the mechanistic plausibility is strong — the fatty acid profile predicts LDL-lowering and anti-inflammatory effects from first principles — and the existing trials are directionally consistent. Macadamia nuts are a reasonable whole-food choice for cardiovascular health, particularly as a replacement for saturated fat sources or refined snacks.
References
- Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic menGarg ML, Blake RJ, Wills RBH. Journal of Nutrition, 2003. PubMed 12672919 →
- A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and womenGriel AE, Cao Y, Bagshaw DD, Cifelli AM, Holub B, Kris-Etherton PM. Journal of Nutrition, 2008. PubMed 18356332 →
- Macadamia nut effects on cardiometabolic risk factors: a randomised trialJones JL, Sabaté J, Heskey C, Oda K, Miles F, Rajaram S. Journal of Nutritional Science, 2023. PubMed 37180485 →
- Macadamia nut consumption modulates favourably risk factors for coronary artery disease in hypercholesterolemic subjectsGarg ML, Blake RJH, Wills RBH, Clayton EH. Lipids, 2007. PubMed 17437143 →
- Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nutMaguire LS, O'Sullivan SM, Galvin K, O'Connor TP, O'Brien NM. International Journal of Food Science and Nutrition, 2004. PubMed 15223592 →
- Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, Brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnutsBolling BW, Chen CY, McKay DL, Blumberg JB. Nutrition Research Reviews, 2011. PubMed 22153059 →
Transparency
View edit historyEvery change to this page is tracked in version control. If you have conflicting research or think something is wrong, we want to hear about it.